Pancreatic Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Oct 23, 2018
- Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis.
Grassi Elisa et al. International journal of oncology 2018 Jun 52(6) 1972-1980 - CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.
Szlachta Karol et al. Nature communications 2018 Oct 9(1) 4275 - High prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
Bannon Sarah A et al. Cancer prevention research (Philadelphia, Pa.) 2018 Oct - Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Walker Evan J et al. Familial cancer 2018 Sep - Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program.
Lucas Aimee L et al. Journal of genetic counseling 2017 Aug 26(4) 806-813 - Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias Sandra et al. Digestive diseases and sciences 2018 63(9) 2351-2361 - Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Zhigang et al. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 49(2) 678-695 - Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer.
Macklin Sarah K et al. Frontiers in oncology 2018 8330 - Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou Xin et al. Gene 2018 Oct 673181-193 - Pancreatic cancer survival analysis defines a signature that predicts outcome.
Raman Pichai et al. PloS one 2018 13(8) e0201751
.png)
No hay comentarios:
Publicar un comentario